Hemogenyx Pharmaceuticals PLC Capital Reinvestment Ratio

Latest as of June 2017: 0.47x

Hemogenyx Pharmaceuticals PLC capital reinvestment ratio. Hemogenyx Pharmaceuticals PLC (HEMO) has a Capital Reinvestment Ratio of 0.47x as of June 2017, meaning it reinvests 0% of its operating cash flow (GBX23.26) in capital expenditures (GBX11.02). Check cash flow reinvestment rate of Hemogenyx Pharmaceuticals PLC to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.47x

Capex / Operating Cash Flow

Operating Cash Flow

GBX23.26

GBX

Capital Expenditures

GBX11.02

GBX

Data as of

Jun 2017

Most recent filing

Hemogenyx Pharmaceuticals PLC Capital Reinvestment Ratio by Year (None–None)

Hemogenyx Pharmaceuticals PLC capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see Hemogenyx Pharmaceuticals PLC cash conversion from operations.

Year	Reinvestment Ratio	Operating CF (GBX)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow